A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer-Reference-Cited by-同舟云学术

A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer

Published:2013-10-31 Issue:1 Volume:58 Page:132-138
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Sharma Chandresh,Khan M. A.,Mohan Teena,Shrinet Jatin,Latha N.,Singh Neeta

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-013-8447-2.pdf

Reference27 articles.

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796–802.

2. Hausen HZ. Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55–78.

3. Roden R, Wu TC. How will HPV vaccines affect cervical cancer? Nat Rev Cancer. 2006;6(10):753–63.

4. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer. 2003;106(6):896–904.

5. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 2003;95(17):1336–43.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers;Cancers;2020-07-05

2. Polymer-based nanoadjuvants for hepatitis C vaccine: The perspectives of immunologists;NANOMED J;2020

3. Cancer Immunoinformatics: A Promising Era in the Development of Peptide Vaccines for Human Papillomavirus-induced Cervical Cancer;Current Pharmaceutical Design;2019-01-15

4. Effect of pleurotus sajor-caju polysaccharide encapsulated in poly D, L lactide-co-glycolide nanoparticles for HPV vaccine in murine model;NANOMED J;2018

5. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor;International Journal of Nanomedicine;2017-09